Fundraising Fox

Lilly Ventures

Seed–Late Stage

Fox Verdict
Sign up to see your fit
Stage
Seed–Late Stage
Tracked investments
3

What they invest in

from 3 of 3 portfolio companies

Biotech ×3Deep Tech ×1Healthtech ×1

HQs:United States×3

Investments · 3 tracked

founders shown can be your intro path

By year:2025 · 12015 · 12 dated

Protagonist Therapeuticsprotagonist-inc.comin𝕏NASDAQ: PTGXJul 2015

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

BiotechHealthtechMilpitas, US

Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)

BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)

Co-investorsAisling CapitalCanaan PartnersJJDCStarfish Ventures

Quarry Theraquarrythera.comFeb 2025

Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds.

BiotechDeep TechNew Haven, US

Craig Crews(Co-Founder & Scientific Advisor)inDan McHugh(Manager)Tim Shannon(CEO and Board Member)inJeanne Magram(Chief Scientific Officer)inKanak Raina(Chief Technology Officer)Sean Cassidy(Chief Financial Officer)in

Co-investorsF-Prime CapitalYosemiteF-Prime Capital PartnersCanaan Partners

Symic Biomedical

BiotechSan Francisco, US

KENNETH N. HORNE(Executive Officer, Director)KATE STUART(Executive Officer)ALYSSA PANITCH(Director)JOHN PADERI(Director)

Co-investorsMitsui Global InvestmentAlly Bridge GroupInCube Ventures

Exits · 1

IPOs and acquisitions across the tracked portfolio

Protagonist TherapeuticsNASDAQ: PTGX

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Lilly Ventures invest at?
Lilly Ventures invests at the Seed, Late Stage stages.

Similar investors

Featured in lists